Testing effectiveness (Phase 2)Study completedNCT01221675
What this trial is testing
TF2- Small Cell Lung Cancer Radio Immunotherapy
Who this might be right for
Small Cell Lung CancerCEA-expressing Non Small Cell Lung Carcinoma (NSCLC)
Centre René Gauducheau 18